Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Nazarbayev University Details Findings in Photocatalytics (Photocatalytic and Adsorption Performance of Mxene@ag/cryogel Composites for Sulfamethoxazole and Mercury Removal From Water Matrices).
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- Additional Information
- Abstract:
Astana, Kazakhstan, Asia, Aniline Compounds, Drugs and Therapies, Emerging Technologies, Nanotechnology, Organic Chemicals, Photocatalyst, Photocatalytics, Sulfamethoxazole, Sulfanilamides, Sulfones, Sulfur Compounds Keywords for this news article include: Astana, Kazakhstan, Asia, Aniline Compounds, Drugs and Therapies, Emerging Technologies, Nanotechnology, Organic Chemicals, Photocatalyst, Photocatalytics, Sulfamethoxazole, Sulfanilamides, Sulfones, Sulfur Compounds, Nazarbayev University. Keywords: Astana; Kazakhstan; Asia; Aniline Compounds; Drugs and Therapies; Emerging Technologies; Nanotechnology; Organic Chemicals; Photocatalyst; Photocatalytics; Sulfamethoxazole; Sulfanilamides; Sulfones; Sulfur Compounds EN Astana Kazakhstan Asia Aniline Compounds Drugs and Therapies Emerging Technologies Nanotechnology Organic Chemicals Photocatalyst Photocatalytics Sulfamethoxazole Sulfanilamides Sulfones Sulfur Compounds 1511 1511 1 11/06/23 20231110 NES 231110 2023 NOV 10 (NewsRx) -- By a News Reporter-Staff News Editor at Drug Week -- Current study results on Nanotechnology - Photocatalytics have been published. [Extracted from the article]
- Abstract:
Copyright of Drug Week is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
No Comments.